Welcome to Markets Desk, your midday read on what's moving money and markets.
The SEC has published proposed rules establishing a formal legal framework for crypto custody, targeting the wealth management and advisory space. This is a significant regulatory step, signaling Washington's intent to bring digital asset safekeeping under the same institutional discipline applied to traditional securities. Advisors and custodians will be watching closely.
Shifting to biotech, Summit Therapeutics has closed a two billion dollar strategic equity investment from AstraZeneca, earmarked for the accelerated development of ivonescimab, a bispecific antibody targeting both PD-one and VEGF pathways. That kind of capital commitment from a major pharma player is a strong vote of confidence in Summit's oncology pipeline and its competitive positioning in the immuno-oncology race.
Meanwhile, a sobering note from the consumer credit front, where a veteran mortgage loan officer is sounding alarms about household overspending among even high-income borrowers. The warning is pointed, drawing comparisons to pre-two thousand eight conditions and suggesting that financial stress is building quietly beneath the surface of what still looks, on paper, like a resilient consumer economy.
That's the tape. Markets Desk, signing off the floor.
